ArticleGut pathogens2026
Enhanced pathogen detection and gut microbiome alterations in pyogenic liver abscess: insights from next-generation sequencing.
Article in Gut pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
objectivesPyogenic liver abscess (PLA) is a life-threatening infection with high mortality in Asia. Although Klebsiella pneumoniae is commonly implicated, emerging data suggest a more diverse microbial spectrum. This study investigated pathogen detection using conventional culture and next-generation sequencing (NGS) and characterized gut microbiome alterations in PLA patients compared to healthy controls.
methodThis was a prospective, multicenter cohort study conducted across eight tertiary hospitals. We enrolled 100 PLA patients who underwent percutaneous aspiration. Abscess aspirates underwent both conventional culture and 16 S rRNA-based NGS. Stool samples from PLA patients and 100 healthy controls were analyzed for gut microbiome composition using NGS.
resultsCulture positivity was 82%, with abscess cultures positive in 77 cases and blood cultures in 32. K. pneumoniae was the most frequently isolated pathogen (67%), and polymicrobial infections were identified in only 3% of cases by culture. NGS of abscess aspirates was available in 92% of patients, including 15 culture-negative cases. NGS identified polymicrobial infections in 16.3% of patients-more than fivefold higher than culture. Among 77 patients who underwent both culture and NGS, 13 (16.9%) showed discordance, mostly due to polymicrobial or anaerobic organisms identified by NGS. Stool NGS analysis revealed significantly reduced alpha diversity in PLA patients compared to healthy controls (Shannon index 2.9 vs. 3.5, p < 0.001), increased abundance of Enterococcus species (27.1% vs. 8.6%, p < 0.001), and depletion of SCFA-producing genera including Faecalibacterium, Roseburia, and Lachnospira species. Despite K. pneumoniae dominance in abscesses, its stool abundance did not significantly differ between PLA patients and controls.
conclusionNGS improves the detection of anaerobes and mixed infections in PLA. The gut microbiota of PLA patients shows marked dysbiosis, suggesting a potential role in disease pathogenesis and future therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.